Sexual Dimorphism in T Cell Exhaustion and Bladder Cancer
T 细胞耗竭和膀胱癌中的性别二态性
基本信息
- 批准号:10629078
- 负责人:
- 金额:$ 53.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-01 至 2028-05-31
- 项目状态:未结题
- 来源:
- 关键词:AdoptedAggressive behaviorAndrogen ReceptorAndrogensAntitumor ResponseBiologicalCD8-Positive T-LymphocytesCD8B1 geneCancer ModelCell ProliferationCell SurvivalCellular biologyChromosomesChronicCollaborationsDataEnvironmentEpigenetic ProcessFemaleFrequenciesFunctional disorderGenesGenetic TranscriptionGoalsGonadal Steroid HormonesHormonesImmuneImmune EvasionImmune responseImmunityImmunologicsImmunologyImmunotherapyIn VitroIncidenceKnowledgeLinkMalignant NeoplasmsMalignant neoplasm of urinary bladderMediatingMolecularMolecular TargetMusOrganPopulationProductionPrognosisProteinsPublishingReceptor SignalingRejuvenationReportingRisk FactorsRoleScienceSex BiasSex ChromosomesSex DifferencesSignal TransductionSmokingT cell differentiationT cell responseT-Cell ReceptorT-LymphocyteTumor-Infiltrating LymphocytesWomanWorkZinc Fingersandrogen deprivation therapyanti-PD-1anti-PD1 therapycancer immunotherapycancer subtypescell typechromosome Y losseffector T cellexhaustexhaustiongene networkimmune checkpoint blockadeimmune functionimprovedin vivomalemennuclear factors of activated T-cellsprogenitorprogramsresponsesexsexual dimorphismsingle-cell RNA sequencingtranscription factortumortumor microenvironmenttumor progression
项目摘要
PROJECT 1 – SUMMARY
Sex is an understudied biological variable with significant influence on immune function, including in the context
of cancer. However, the immunological mechanisms underlying the sex bias seen in cancers from non-
reproductive organs, such as bladder cancer (BC), remain elusive. Male bias in BC incidence persists after
adjustment for other known risk factors suggesting a fundamental biological basis for this sexual dimorphism.
Objective: To define the molecular mechanisms by which androgens, AR target genes, and sex chromosome-
encoded epigenetic modifiers contribute to sex differences in CD8+ T cell exhaustion in the tumor
microenvironment (TME). Impact: Our study will uncover an immunological basis and mechanism by which
CD8+ T cell exhaustion contributes to sex bias in BC, with implications for improving ICB approaches for all
cancer via three specific aims. Aim 1: Determine the role of AR-TCF1 and AR-TOX in CD8+ T cell exhaustion
and tumor control. The molecular mechanisms by which androgens influence T cells and contribute to cancer
progression are unclear. Male CD8+ tumor-infiltrating lymphocytes (TILs) preferentially adopt a TCF1+ PE state
due to direct activation of Tcf7 by AR. Hypothesis. Androgen signaling establishes a stable TCF1-driven
transcriptional network in CD8+ T cells that favors exhaustion, through the modulation of TOX, another critical
transcription factor (TF) that promotes T cell exhaustion. Aim 2: Determine the role of AR-ZFP148 in T cell
effector differentiation. TF ZFP148 regulates cell proliferation and survival in non-immune cell types but has
not been studied in T cell biology. Single-cell RNA-seq analyses demonstrated male-biased Zfp148 expression
and regulatory activity in PE CD8+ T cells stimulated by AR. T cell receptor (TCR) engagement and chronic
exhaustion induced Zfp148 expression in CD8+ T cells, and its deletion led to better effector function in vitro. The
in vivo persistence of Zfp148 null T cells was compromised. Hypothesis. AR-regulated ZFP148 can suppress
CD8+ T cell effector function and contributes to male-biased BC. Aim 3: Investigate the role of AR and
epigenetic modifiers in CD8+ T cell exhaustion and tumor response to immunotherapy. The impact of sex
chromosome-encoded epigenetic modifiers in BC – including KDM5D, UTY, and KDM6A – on immunity
especially in the CD8+ compartment is a major gap in the field. In collaboration with Project 2, we found that loss
of the Y chromosome (LOY) (especially the genes Kdm5d and Uty) contributes to CD8+ T cell exhaustion in BC.
Hypothesis. Sex hormones and sex chromosome-encoded epigenetic modifiers contribute to CD8+ T cell
exhaustion and BC sensitivity to ICB.
项目1 -总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zihai Li其他文献
Zihai Li的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zihai Li', 18)}}的其他基金
Targeting GRP94-TGF-beta Pathway for Cancer Immunotherapy Supplement
靶向 GRP94-TGF-β 通路的癌症免疫治疗补充剂
- 批准号:
10818173 - 财政年份:2021
- 资助金额:
$ 53.14万 - 项目类别:
Targeting GRP94-TGF-beta Pathway for Cancer Immunotherapy
靶向 GRP94-TGF-β 通路的癌症免疫治疗
- 批准号:
10474548 - 财政年份:2021
- 资助金额:
$ 53.14万 - 项目类别:
Targeting GRP94-TGF-beta Pathway for Cancer Immunotherapy
靶向 GRP94-TGF-β 通路的癌症免疫治疗
- 批准号:
10689068 - 财政年份:2021
- 资助金额:
$ 53.14万 - 项目类别:
Targeting GRP94-TGF-beta Pathway for Cancer Immunotherapy
靶向 GRP94-TGF-β 通路的癌症免疫治疗
- 批准号:
10275810 - 财政年份:2021
- 资助金额:
$ 53.14万 - 项目类别:
Integration of inflammation and cancer by molecular chaperone
分子伴侣整合炎症和癌症
- 批准号:
10056559 - 财政年份:2017
- 资助金额:
$ 53.14万 - 项目类别:
Endoplasmic Reticulum Chaperones in Cancer Biology and Therapy
癌症生物学和治疗中的内质网伴侣
- 批准号:
9321008 - 财政年份:2015
- 资助金额:
$ 53.14万 - 项目类别:
Project 1: Definition of grp94-GARP-TGFbeta Axis in Cancer Biology and Clinical Significance
项目1:grp94-GARP-TGFbeta轴在癌症生物学中的定义及其临床意义
- 批准号:
8934513 - 财政年份:2015
- 资助金额:
$ 53.14万 - 项目类别:
Novel mechanisms of UPR sensing and nonalcoholic fatty liver disease
UPR传感和非酒精性脂肪肝的新机制
- 批准号:
9026108 - 财政年份:2015
- 资助金额:
$ 53.14万 - 项目类别:
Endoplasmic Reticulum Chaperones in Cancer Biology and Therapy
癌症生物学和治疗中的内质网伴侣
- 批准号:
8934510 - 财政年份:2015
- 资助金额:
$ 53.14万 - 项目类别:
Endoplasmic Reticulum Chaperones in Cancer Biology and Therapy
癌症生物学和治疗中的内质网伴侣
- 批准号:
9770790 - 财政年份:2015
- 资助金额:
$ 53.14万 - 项目类别:
相似海外基金
Relationship between two types of narcissism, anger, aggressive behavior and adaptation
两种自恋、愤怒、攻击行为和适应之间的关系
- 批准号:
23K18995 - 财政年份:2023
- 资助金额:
$ 53.14万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Molecular biomarkers of future aggressive behavior in pituitary tumors
垂体瘤未来攻击行为的分子生物标志物
- 批准号:
10650948 - 财政年份:2023
- 资助金额:
$ 53.14万 - 项目类别:
Neuronal mechanisms of visually-driven aggressive behavior
视觉驱动攻击行为的神经机制
- 批准号:
9978478 - 财政年份:2020
- 资助金额:
$ 53.14万 - 项目类别:
Development of a Nursing Intervention Model to Prevent Aggressive Behavior in Hospitalized Elderly Patients with Dementia
预防住院老年痴呆症患者攻击行为的护理干预模型的建立
- 批准号:
20K23236 - 财政年份:2020
- 资助金额:
$ 53.14万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Development of a Management Sheet on Aggressive Behavior for Working with Patients in a Psychiatric Ward
为精神科病房的患者制定攻击行为管理表
- 批准号:
18K10309 - 财政年份:2018
- 资助金额:
$ 53.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Social determinants of corticolimbic development and aggressive behavior
皮质边缘发育和攻击行为的社会决定因素
- 批准号:
9765038 - 财政年份:2018
- 资助金额:
$ 53.14万 - 项目类别:
Examination of factors that promote and suppress aggressive behavior on the Internet
检查促进和抑制互联网上攻击行为的因素
- 批准号:
17K04438 - 财政年份:2017
- 资助金额:
$ 53.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identifying patterns and mechanistic pathways from violence exposure trajectories to aggressive behavior and psychological disorders
识别从暴力暴露轨迹到攻击行为和心理障碍的模式和机制路径
- 批准号:
9372567 - 财政年份:2017
- 资助金额:
$ 53.14万 - 项目类别:
EAPSI: The Role of Monoamine Oxidase - A Gene Polymorphism in Aggressive Behavior in Macaques
EAPSI:单胺氧化酶的作用 - 基因多态性在猕猴攻击行为中的作用
- 批准号:
1713932 - 财政年份:2017
- 资助金额:
$ 53.14万 - 项目类别:
Fellowship Award
analysis on genetic abnormality related to aggressive behavior of uterine leiomyosarcoma
子宫平滑肌肉瘤侵袭行为相关基因异常分析
- 批准号:
16K11124 - 财政年份:2016
- 资助金额:
$ 53.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




